Different roles of pro-inflammatory cytokines interleukin-1 beta and tumor necrosis factor in mechanical hyperalgesia induced by spared nerve injury in rats

Chinese Journal of Clinical Rehabilitation

Volumn 8, Issue 13, 2004, Pages 2538-2540

  Feng, Si Zhe ^a   Wei, Xue Zhong ^b   Zhang, Xiang ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE RELEASE; GLIA CELL; HINDLIMB; HYPERALGESIA; INHIBITION KINETICS; MALE; MECHANICAL STIMULATION; MILITARY MEDICINE; NERVE INJURY; NONHUMAN; RAT; SPINAL CORD; TREATMENT OUTCOME;

EID: 3543128852     PISSN: 16715926     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Hökfelt T, Zhang X, Wiesenfeld-Hallin Z. Messenger plasticity in primary sensory neurons following axotomy and its functional implications. Trends Neurosci 1994; 17: 22 - 30
2. + channel immunolocalization in peripheral mammalian axons and changes following nerve injury and neuroma formation. J Neurosci 1993; 13: 1976 - 92
3. Woolf, CJ, Shortland P. and Coggeshall RE, Peripheral nerve injury triggers central sprouting of myelinated afferents. Nature 1992; 355: 75 - 8
4. Sweitzer SM, Martin D, Deleo JA. Intrathecal interleukin-1 receptor antagonist in comination with soluble tumor necrosis receptors factor exhibits an anti-allodynic action in a rat model of neuropathic pain. Neuroscience 2001; 103: 529 - 39
5. Watkins LR, Maier SF. Beyond neurons: evidence that immune and glial cells contribute to pathological pain states. Physiol Rev 2002; 82: 981 - 1011
6. Watkins LR, Maier SF. Glia: a novel drug discovery target for clinical pain. Nature Rev. Drug Discovery 2003; 2: 973 - 85
7. Pan Y, Zhou Y. A pilot study of the role of glial cell line-derived neurotrophic factor in the pain regulation. Zhongguo Linchuang Kangfu 2003; 7 (6): 924 - 5 (China)
8. Yu LH, Kang DZ, Lin JH, et al. Application of mesenchymal stem cell in tissue repair and functional reconstruction after nerve injury. Zhongguo Linchuang Kangfu 2003; 7 (28): 3872 - 3 (China)
9. Liu HM, Liu J, Wei YZ, et al. Effect of basic fibroblast growth factor on muscle after nerve injury in rats. Zhongguo Linchuang Kangfu 2003; 7 (19): 2676 - 7 (China)
10. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983; 16: 109 - 10
11. Zheng JH, Chen J. Modulatory roles of the adenosine triphosphate P2xpurinoceptor in generation of the persistent nociception induced by subcutaneous bee venom injection in the conscious rat. Neurosci Lett 2000; 278: 41 - 4
12. Decosterd I, Woolf CJ. Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain 2000; 87: 149 - 58
13. Watkins LR, Martin D, Ulrich P, et al. Evidence for the involvement of spinal cord glia in subcutaneous formalin induced hyperalgesia in the rat Pain 1997; 71: 225 - 35
14. Sommer C, Petrausch S, Lindenlaub T, et al. Neutralizing antibodies to interleukin 1-receptor reduce pain associated behavior in mice with experimental neuropathy. Neurosci Lett 1999; 270: 25 - 8
15. Cunha JM, Cunha FQ, Poole S, et al. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist. B J Pharmacol 2000; 130: 1418 - 24
16. Lindenlaub T, Teuteberg P, Hartung T, et al. Effects of neutralizing antibodies to TNF-alpha on pain-related behavior and nerve regeneration in mice with chronic constriction injury. Brain Res 2000; 866: 15 - 22